|
|
Article: Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center.
- Article from:
- NewsRx Health
- Article date:
- October 26, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Oncologists at the Moores Cancer Center at the University of California, San Diego (UCSD) in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of cancer vaccine. While many vaccines attempt to pump up the immune system to fight off a cancer, the new vaccine, Lucanix, is genetically engineered to also trick the cancer into turning off its immune system-suppressing activities.
The first patients have begun enrolling in a new clinical trial at the Moores UCSD Cancer Center testing the effectiveness of the vaccine. The trial will involve 700 patients at some 90 centers worldwide.
Current ...
Related newspaper, magazine, and journal articles:
|
|
Article: NOVEL LUNG CANCER VACCINE TRIAL LAUNCHED AT MOORES ...
US Fed News Service, Including US State News;
October 8, 2008 ;
700+ words
... ... Oncologists at the Moores Cancer Center at the University ... march of advanced lung cancer by treating patients ... director of the Lung Cancer Unit at the Moores UCSD Cancer Center and assistant clinical ... treatments for advanced lung cancer may involve ...
|
|